Search
for
Sort by
Research 391–420 of 777
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Novel TMEM173 Mutation and the Role of Disease Modifying Alleles
- Baricitinib: From Rheumatoid Arthritis to COVID‐19
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Ruxolitinib for the treatment of severe alopecia areata
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- STAT5 Activation in the Dermal Papilla Is Important for Hair Follicle Growth Phase Induction
- Treatment of severe alopecia areata with baricitinib
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Successful treatment of alopecia universalis with abrocitinib: a case report
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Alopecia universalis successfully treated with tofacitinib
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Efficacy of tofacitinib in pediatric alopecia universalis
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata